Zymo Research is a globally established biotechnology company and industry leader in the fields of epigenetics, microbiomics and the emerging Next-Gen Sequencing space. With international facilities and a global distribution network, Zymo Research enables researchers in academia and the biomedical field to make cutting-edge discoveries all over the world. While the company provides some of the most technologically advanced products in the industry, everything is driven by the fundamental belief that “the beauty of science is to make things simple.”
VivoxBio, Inc
Our approach combines clinically relevant humanized cancer models, real-time imaging, and precision oncology techniques to: Accelerate drug development timelines Enhance screening efficiency Develop innovative tumor-targeting and monitoring solutions We strive to transform cancer into a manageable chronic condition by disrupting its evolutionary mechanisms, offering renewed hope to patients globally.
Virchow Medical, Inc.
Virchow’s mission is to unlock critical molecular data for every cancer patient and enable precision medicine to save more lives. It does this by providing its hospital subscribers with a monthly supply of Crow’s Nest® Biopsy Catchment System units, which are used after core needle tumor biopsies to create Liquid Companion Specimens (LCSs). The company stores the LCSs for its customers in a unique biorepository, the Virchow Vault,TM housed in a CAP-accredited facility. The result is that oncologists can log on to www.virchowvault.com at any time after their patient’s biopsy and order genomic sequencing or other molecular testing without requesting their hospital’s pathology department to provide any of the tissue block. In an era which Formalin-Fixed Paraffin-Embedded (FFPE) tissue is limited and often insufficient, this ability to order sequencing using only high-quality material that is normally discarded on used needles is designed to provide every biopsy patient the opportunity to be treated with precision medicine targeted therapy. For further information, visit www.virchowmed.com, and follow Virchow on LinkedIn at https://www.linkedin.com/company/virchowmed/.
VION Biosciences
VION Biosciences is a specialized life science platform company focused on manufacturing and supplying mission-critical reagents, specialty chemicals, and assay kits for research, diagnostics, and drug development. We provide integrated, high-quality materials—including lipid nanoparticles and custom formulations—from discovery to commercialization. VION Biosciences aims to accelerate scientific research and clinical testing through innovation and flexible manufacturing solutions.
US Biolab
US Biolab is a global biobank providing access to a wide variety of human biospecimens, covering healthy and multiple disease states to support researchers’ projects. We offer comprehensive molecular pathology services, including tissue processing, fixation, embedding, sectioning, H&E staining, custom tissue arrays, immunohistochemistry (IHC), special staining, in situ hybridization (ISH), microdissection, DNA and RNA extraction, digital pathology services, polymerase chain reaction (PCR), next-generation sequencing (NGS), and more.
TubeWriter
TubeWriter labeling systems is a full-feature instrument for printing directly at high-speed on the sides and caps of plastic, glass, and curved surfaces, including tubes, vials, slides, plates and custom labware. It is designed to address automating laboratory printing for assays, protocols and experiments. TubeWriter labeling withstands the harshest of lab conditions; resistant to chemical solvents and surviving long-term storage at -80C and liquid nitrogen. | TubeWriter is an automated labeling systems that prints directly on the surface of any labware eliminating the need for sticky labels. For laboratories that perform medium to high-throughput applications struggling with manual labeling or paper labels, the TubeWriter prints directly on the sides and caps of tubes, vials, plates and unique labware. TubeWriter prints text, images, and barcodes using UV-curable ink that withstands extreme lab conditions, most harsh chemicals and long-term storage at -80C and liquid nitrogen.
Trepte Biostorage
Trepte Biostorage is a San Diego–based biorepository providing secure, GxP-aligned storage for biotech and pharmaceutical teams. We support cell and gene therapy, biologics, and translational research programs with vapor-phase LN2, -80C, -20C, +4C, and ambient storage. Our facility features validated equipment, continuous monitoring, and full chain-of-custody tracking to ensure sample integrity and regulatory readiness. Trepte partners with growing and established teams seeking reliable long-term storage, redundancy, and disaster recovery solutions.
The Cancer Epitope Database and Analysis Resource (CEDAR)
The Cancer Epitope Database and Analysis Resource (CEDAR – cedar.iedb.org) is a freely available resource funded by NCI. It catalogs experimental data on antibody and T cell epitopes studied in humans in the context of cancer disease. CEDAR also hosts tools to assist in the prediction and analysis of cancer epitopes. CEDAR is a companion site to the Immune Epitope Database (IEDB – iedb.org), which is funded by NIAID, and houses epitope data on infectious disease, allergy, autoimmunity and transplantation.
TETHIS SPA
Tethis S.p.A., an Italian diagnostic firm, has pioneered titanium dioxide–nanocoated SmartBioSurface® slides that enable in‑situ analysis of typically non‑adherent cells – including primary cells, stem cells, and PBMCs. These slides are ideally suited for multiplex and multiomic assays, advanced spatial biology techniques, and precise single‑cell laser‑capture microdissection. In addition, Tethis has developed See.d®, an automated instrument for pre‑analytical sample preparation in liquid biopsy. See.d® introduces a new level of standardization and reliability by fully automating plasma and cytology sample processing – addressing two major unmet needs in liquid biopsy workflows: the lack of reproducible, standardized pre‑analytical protocols and the difficulty of visualizing and analysing rare tumor and immune cells on microscopy slides.